Format
Items per page
Sort by

Send to:

Choose Destination

Results: 11

1.

Associations Between Sildenafil Use and Changes in Days of Hospitalization in a Population With Pulmonary Arterial Hypertension Associated With Connective Tissue Disease.

Yang X, Sanders KN, Mardekian J, Mychaskiw MA, Thomas J 3rd.

Clin Ther. 2015 May 1;37(5):1055-63. doi: 10.1016/j.clinthera.2015.02.025. Epub 2015 Mar 26.

PMID:
25818118
2.

Prevalence of pulmonary arterial hypertension in patients with connective tissue diseases: a systematic review of the literature.

Yang X, Mardekian J, Sanders KN, Mychaskiw MA, Thomas J 3rd.

Clin Rheumatol. 2013 Oct;32(10):1519-31. doi: 10.1007/s10067-013-2307-2. Epub 2013 Jun 20. Review.

3.

Changes in healthcare utilization and costs associated with sildenafil therapy for pulmonary arterial hypertension: a retrospective cohort study.

Berger A, Edelsberg J, Teal S, Mychaskiw MA, Oster G.

BMC Pulm Med. 2012 Dec 11;12:75. doi: 10.1186/1471-2466-12-75.

4.

Assessment of measurement properties of peak VO(2) in children with pulmonary arterial hypertension.

Cappelleri JC, Hwang LJ, Mardekian J, Mychaskiw MA.

BMC Pulm Med. 2012 Sep 10;12:54. doi: 10.1186/1471-2466-12-54.

5.
6.

Association of subjective anxiety, depression, and sleep disturbance with quality-of-life ratings in adults with epilepsy.

Kwan P, Yu E, Leung H, Leon T, Mychaskiw MA.

Epilepsia. 2009 May;50(5):1059-66. doi: 10.1111/j.1528-1167.2008.01938.x. Epub 2008 Dec 15.

PMID:
19170734
7.

An assessment of readiness for behaviour change in patients prescribed ocular hypotensive therapy.

Schwartz GF, Plake KS, Mychaskiw MA.

Eye (Lond). 2009 Aug;23(8):1668-74. doi: 10.1038/eye.2008.337. Epub 2008 Nov 14.

PMID:
19011605
8.

Cost-effectiveness of treating ocular hypertension.

Stewart WC, Stewart JA, Nasser QJ, Mychaskiw MA.

Ophthalmology. 2008 Jan;115(1):94-8. doi: 10.1016/j.ophtha.2007.01.040. Erratum in: Ophthalmology. 2008 Sep;115(9):1524. Nassar, Qasiem J [corrected to Nasser, Qasiem J].

PMID:
18166406
9.

Ocular blood flow in glaucoma: the need for further clinical evidence and patient outcomes research.

Stewart WC, Feldman R, Mychaskiw MA.

Br J Ophthalmol. 2007 Oct;91(10):1263-4. Review. No abstract available.

10.
11.

Accounting for restart rates in evaluating persistence with ocular hypotensives.

Schwartz GF, Platt R, Reardon G, Mychaskiw MA.

Ophthalmology. 2007 Apr;114(4):648-52.

PMID:
17398318
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk